Skip to main content

Azacitidine plus enasidenib improves response, but not survival, in mIDH2 AML

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Azacitidine plus enasidenib improves response, but not survival, in mIDH2 AML

User login

Username

Password

Reset your password

Type	Lead	score